All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls · page 30 of 45
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
-
Class IIofficial
Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-Release TabletsPresence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
-
Class IIofficial
Eugia US LLC recalls Progesterone Injection USPPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.
-
Class IIofficial
Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8 mgFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
-
Class IIofficial
Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 4 mgFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
-
Class IIofficial
First Aid Beauty Ltd recalls First Aid Beauty Ultra Repair CreamCGMP Deviations; product intended for quarantine was inadvertently distributed
-
Class Iofficial
Astellas Pharma US Inc. recalls Astagraf XL (tacrolimus extended-release capsules) 0.5 mgFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
-
Class Iofficial
Astellas Pharma US Inc. recalls Prograf (tacrolimus) capsulesFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium TabletsFailed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
-
Class Iofficial
ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal SolutionLabeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
-
Class IIofficial
Hikma Injectables USA Inc recalls ketamine inj 50 mg per 1 mLLack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
-
Class IIofficial
Hikma Injectables USA Inc recalls phenylephrine in 0.9% Sodium Chloride InjLack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
-
Class IIIofficial
West-Ward Columbus Inc recalls Methadone Hydrochloride TabletsFailed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.
-
Class IIIofficial
AvKARE recalls Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye DropsLABELING: LABEL MIX-UP
-
Class IIIofficial
AvKARE recalls Polyvinyl Alcohol Ophthalmic Solution 1.4%LABELING: LABEL MIX-UP
-
Class IIofficial
Eugia US LLC recalls medroxyPROGESTERone Acetate Injectable SuspensionCGMP Deviations
-
Class IIofficial
Granules Pharmaceuticals Inc. recalls Colchicine Capsules 0.6 mgFailed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
-
Class Iofficial
Alcon Research LLC recalls Systane Lubricant Eye DropsNon-Sterility
-
Class IIofficial
Amerisource Health Services LLC recalls glipiZIDEFailed Dissolution Specifications:
-
Class IIIofficial
Somerset Therapeutics LLC recalls Atropine Sulfate Ophthalmic SolutionFailed Impurities/Degradation Specifications
-
Class IIofficial
FDC Limited recalls Ciprofloxacin Ophthalmic Solution USPDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
-
Class Iofficial
Shoppers- Plaza recalls FOUZEE SugarLin HERBAL FORMULA capsulesMarketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
-
Class IIofficial
Amerisource Health Services LLC recalls Clobazam TabletsPresence of Foreign Tablets/Capsules
-
Class IIofficial
Ascend Laboratories, LLC recalls Dabigatran EtexilateCGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
-
Class IIofficial
Ascend Laboratories, LLC recalls Dabigatran EtexilateCGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
-
Class Iofficial
GNMart LLC recalls FORCE FOREVER 400mg TabletsMarketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.
-
Class Iofficial
Buy-Herbal recalls Nhan Sam Tuyet Lien Truy Phong HoanMarketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and Chlorpheniramine
-
Class IIIofficial
Akron Pharma, Inc. recalls Acetaminophen Extra Strength 500 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIIofficial
Akron Pharma, Inc. recalls Acetaminophen Regular StrengthLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIIofficial
Akron Pharma, Inc. recalls AcetaminophenLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIIofficial
Akron Pharma, Inc. recalls Acetaminophen Extra Strength 500 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIIofficial
Akron Pharma, Inc. recalls Diphenhydramine HCl 25 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIIofficial
Akron Pharma, Inc. recalls Diphenhydramine HCl 25 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIIofficial
Akron Pharma, Inc. recalls Diphenhydramine HCl 50 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Regenerative Processing Plant, LLC recalls LITE Regener-EyesLack of Sterility Assurance
-
Class IIofficial
Regenerative Processing Plant, LLC recalls PROFESSIONAL Regener-EyesLack of Sterility Assurance
-
Class IIofficial
Viona Pharmaceuticals Inc recalls Dapsone Gel 7.5%Crystallization
-
Class IIofficial
Viona Pharmaceuticals Inc recalls Dapsone Gel 7.5%Crystallization
-
Class IIofficial
Aurobindo Pharma USA Inc recalls Nebivolol TabletsCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
-
Class IIofficial
FDC Limited recalls Timolol Maleate Ophthalmic Solution USPDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
-
Class IIofficial
PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USPCGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
-
Class IIofficial
AvKARE recalls Nitrofurantoin CapsulesFailed Dissolution Specifications